Actilyse

Actilyse (Alteplase) is a recombinant tissue plasminogen activator used for intravenous administration. It is commonly associated with clot-busting therapy and is manufactured by Boehringer Ingelheim B.V. in the EU.

Actilyse is primarily used to dissolve blood clots in the body. It is often administered intravenously to treat conditions related to clot formation, such as ischemic stroke or pulmonary embolism. The medication works by breaking down fibrin, a key component of blood clots, to restore blood flow. What is Actilyse used for? It is typically used in emergency situations where rapid clot dissolution is critical.

Common effects of Actilyse may include bleeding at the injection site or other areas of the body. Patients might also experience bruising or prolonged bleeding from cuts. These effects are generally monitored by healthcare professionals during administration. It is important to note that individual responses to the medication can vary.

Actilyse should be handled with care, as it can increase the risk of bleeding. Patients with a history of bleeding disorders or recent surgery should inform their healthcare provider before use. The medication should be stored and administered under controlled conditions to ensure its effectiveness and safety.

Actilyse may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. It is important to inform healthcare providers about all medications being taken to avoid potential interactions. Alcohol and certain supplements may also influence the effects of Actilyse.